SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel TEL AVIV, Israel, July 14, 2023 -- SciSparc Ltd. , a specialty...

Related Keywords

Israel ,Israeli ,Magister Landsheft ,Yuval Landsheft ,Oz Adler ,National Autism Research Center ,Nasdaq ,Israeli Medical Cannabis Agency ,Soroka University Medical Center Ethics Committee ,Israeli Ministry Of Health ,Scisparc Ltd ,Exchange Commission ,Company Or Scisparc ,Israeli Ministry ,Chief Executive Officer ,Aberrant Behavior Checklist Community ,Clinical Global Impressions Improvement ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,